v3.25.2
12. Stockholders’ equity
3 Months Ended
May 31, 2025
Equity [Abstract]  
12. Stockholders’ equity

12.      Stockholders’ equity 

 

a.       Authorized and issued stock by period

 

Authorized:

 

As of May 31, 2025 the Company had 188,266,250 shares of common stock authorized and available to issue for purposes of satisfying conversion of preferred stock, the exercise and future grant of common stock options, and for purposes of any future business acquisitions and transactions.

 

As of May 31, 2025, Medinotec Inc., the parent Company had 20,000,000 shares of preferred stock authorized and available to issue.

 

This has remained unchanged from the previous financial year ending February 28, 2025.

  

Issued and outstanding shares:

 

      
   May 31 2025  Feb 28 2025
Common shares   11,733,750    11,733,750 
Stock issued            
Total   11,733,750    11,733,750 

 

Share capital:

         
   

May 31 2025

$

 

Feb 28 2025

$

Common shares     11,734       11,734  
Stock issued                  
Total     11,734       11,734